NASDAQ:ABDC - Alcentra Capital Stock Price, News & Analysis

Alcentra Capital trades on the NASDAQ under the ticker symbol "ABDC."

Alcentra Capital announced a quarterly dividend on Monday, August 5th. Stockholders of record on Thursday, September 26th will be given a dividend of $0.18 per share on Thursday, October 3rd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 8.15%. The ex-dividend date of this dividend is Wednesday, September 25th. View Alcentra Capital's Dividend History.

Alcentra Capital announced that its board has approved a share buyback plan on Friday, November 17th 2017, which authorizes the company to repurchase $2,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its stock is undervalued.

Alcentra Capital Corp (NASDAQ:ABDC) released its earnings results on Wednesday, August, 7th. The asset manager reported $0.20 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.20 by $0.00. The asset manager had revenue of $6.14 million for the quarter, compared to the consensus estimate of $6.11 million. Alcentra Capital had a net margin of 31.91% and a return on equity of 8.30%. View Alcentra Capital's Earnings History.

Alcentra Capital is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Alcentra Capital.

News articles about ABDC stock have been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Alcentra Capital earned a news sentiment score of 0.9 on InfoTrie's scale. They also gave news headlines about the asset manager a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Alcentra Capital.

Alcentra Capital saw a drop in short interest in the month of August. As of August 31st, there was short interest totalling 9,400 shares, a drop of 40.9% from the July 31st total of 15,900 shares. Based on an average trading volume of 53,500 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.1% of the shares of the stock are sold short. View Alcentra Capital's Current Options Chain.

Some companies that are related to Alcentra Capital include Fidus Investment (FDUS), Westwood Holdings Group (WHG), Value Line (VALU), Saratoga Investment (SAR), Monroe Capital (MRCC), Silvercrest Asset Management Group (SAMG), StoneCastle Financial (BANX), Great Elm Capital (GECC), Hennessy Advisors (HNNA), Fifth Street Asset Management (FSAM), Manning and Napier (MN), U.S. Global Investors (GROW), Puhui Wealth Investment Managemnt (PHCF), Medley Management (MDLY) and BKF Capital Group (BKFG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcentra Capital investors own include Energy Transfer LP Unit (ET), SunCoke Energy Partners (SXCP), THL Credit (TCRD), Cornerstone Total Return Fund (CRF), Garrison Capital (GARS), Arlington Asset Investment (AI), Capitala Finance (CPTA), CBL & Associates Properties (CBL), NGL Energy Partners (NGL) and SandRidge Permian Trust (PER).

Alcentra Capital's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (5.25%), Pacific Ridge Capital Partners LLC (3.55%), Morgan Stanley (3.41%), Oppenheimer & Co. Inc. (0.22%), Acadian Asset Management LLC (0.13%) and Appleton Partners Inc. MA (0.08%). Company insiders that own Alcentra Capital stock include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Paul J Echausse, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Institutional Ownership Trends for Alcentra Capital.

ABDC stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp and Oppenheimer & Co. Inc.. View Insider Buying and Selling for Alcentra Capital.

ABDC stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Pacific Ridge Capital Partners LLC, Appleton Partners Inc. MA and Acadian Asset Management LLC. Company insiders that have bought Alcentra Capital stock in the last two years include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Insider Buying and Selling for Alcentra Capital.

Shares of ABDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ABDC stock can currently be purchased for approximately $8.83.

Alcentra Capital has a market capitalization of $113.73 million and generates $28.97 million in revenue each year. The asset manager earns $5.52 million in net income (profit) each year or $1.01 on an earnings per share basis. View Additional Information About Alcentra Capital.

The official website for Alcentra Capital is http://www.alcentracapital.com/.

Alcentra Capital's mailing address is 200 PARK AVENUE 7TH FLOOR, NEW YORK NY, 10166. The asset manager can be reached via phone at 212-922-8240 or via email at [email protected]